- Price is above the Trend Line, keeping the weekly tape constructive.
9600
SAU
Week ended 07 Aug 2026
Weekly Investor Report
Qomel Company Limited · Healthcare · Pharmaceutical Retailers
Latest close
50.00 SAR
4.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.8% above the Trend Line and sits at 46.4% of its 52-week range. The latest completed week returned 4.2%, after a 4.2% four-week move. The latest news-sentiment score is 50/100.
Setup score
43
out of 100
Latest Close
50.00 SAR
7 Aug 2026
1W Return
4.2%
latest completed week
4W Return
4.2%
short-term follow-through
12W Return
2.1%
quarterly tape
Trend Breadth
5.8%
3 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.2%
Latest completed week; four-week move 4.2%.
Indicator stack
3/26
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.8% above the Trend Line and sits at 46.4% of its 52-week range. The latest completed week returned 4.2%, after a 4.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.15
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 4.2% over four weeks, 2.1% over 12 weeks, and -5.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year3
Trend breadth5.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.57Latest activity-pressure read.
Pressure change-173.4%Four-week change in activity pressure.
Leadership1.61Latest relative-leadership reading.
RS change150.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.6%Distance below the 52-week high.
13-week volatility1.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2610 weeks finished lower.
Best week+9.7%Week of 3 Apr.
Worst week-8.2%Week of 6 Mar.
Latest week+4.2%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks4
Modest losses6
Sharp losses4
Recent vol1.7%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split25/22Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank6 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Pharmaceutical Retailers
4-week rank1 / 4
Group average-2.9%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD25.0%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 1/12.
Activity pressure 0.08; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Buy Polycab India; target of Rs 9600: Motilal Oswal Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 50.00 SAR | 4.2% | 49.10 SAR | 51.96 SAR | -0.57 | 1.61 | 9.9K | Off |
| 31 Jul 2026 | 48.00 SAR | 0.0% | 49.18 SAR | 51.98 SAR | -0.73 | -0.20 | 4.0K | Off |
| 24 Jul 2026 | 48.00 SAR | 0.0% | 49.38 SAR | 52.01 SAR | -0.66 | -2.40 | 2.6K | Off |
| 17 Jul 2026 | 48.00 SAR | 0.0% | 49.61 SAR | 52.05 SAR | -0.42 | -2.05 | 910 | Off |
| 10 Jul 2026 | 48.00 SAR | 2.1% | 49.99 SAR | 52.09 SAR | -0.21 | -3.19 | 2.7K | Off |
| 3 Jul 2026 | 47.00 SAR | -3.5% | 50.29 SAR | 52.12 SAR | 0.01 | -5.73 | 764 | Off |
| 26 Jun 2026 | 48.70 SAR | 0.1% | 50.39 SAR | 52.17 SAR | 0.12 | -3.48 | 8.5K | Off |
| 19 Jun 2026 | 48.66 SAR | -0.7% | 50.40 SAR | 52.20 SAR | 0.13 | -5.31 | 4.5K | Off |
| 12 Jun 2026 | 49.00 SAR | -0.1% | 50.38 SAR | 52.23 SAR | 0.18 | -4.05 | 13.3K | Off |
| 5 Jun 2026 | 49.04 SAR | 0.0% | 50.35 SAR | 52.26 SAR | 0.15 | -3.74 | 5.5K | Off |
| 29 May 2026 | 49.02 SAR | 0.0% | 50.31 SAR | 52.29 SAR | 0.14 | -4.16 | 0 | Off |
| 22 May 2026 | 49.02 SAR | 0.1% | 50.36 SAR | 52.32 SAR | 0.22 | -4.16 | 32.3K | Off |
| 15 May 2026 | 48.98 SAR | -2.0% | 50.35 SAR | 52.35 SAR | 0.23 | -4.00 | 16.9K | Off |
| 8 May 2026 | 49.98 SAR | -6.1% | 50.36 SAR | 52.39 SAR | 0.27 | -2.50 | 12.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.